Phio Pharmaceuticals Corp. (NASDAQ:PHIO)
| Market Cap | 11.27M-59.9% |
| Revenue (ttm) | 0 |
| Net Income | -12.90M-82.1% |
| EPS | -1.34+100.0% |
| Shares Out | 11.62M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,995.95 |
| Open | 0.97 |
| Previous Close | 1.00 |
| Day's Range | 0.97 - 0.98 |
| 52-Week Range | 0.81 - 4.19 |
| Beta | 0.84 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
Phio Pharmaceuticals Corp. has a live Insider Score.
Scored on 7 qualifying trades from 3 insiders in the last 90 days.
About PHIO
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PHIO stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in PHIO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PHIO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PHIO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New PHIO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PHIO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PHIO
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $102.75K |
Estimated from each fund’s disclosed top holdings × AUM
PHIO Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PHIO’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score